Observational Study on Skeletal Ewing's Sarcoma

Launched by ITALIAN SARCOMA GROUP · Apr 12, 2021

Keywords

ClinConnect Summary

This clinical trial is looking at a type of bone cancer called Ewing's sarcoma, which mainly affects young people. Researchers want to gather important information about patients with this condition, including their age, medical history, treatments, and how the disease affects them. The goal is to better understand Ewing's sarcoma and improve future care.

To be eligible for this study, participants must be diagnosed with Ewing's sarcoma or a similar type of cancer and be under 50 years old at the time of diagnosis. They should also have consent from themselves or their parents/guardians to join the study. Participants will not be able to join if they have other serious health issues that could make treatment difficult. Those who take part in the study can expect regular check-ups and to contribute valuable information that may help others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Diagnosis of Ewing's sarcoma of the bone
• • 2. Diagnosis of Ewing-like sarcoma (round cell sarcoma with fusion of the EWSR1 gene with others not of the ETS family, sarcoma with CIC rearrangement or sarcoma with BCOR rearrangement)
• • 3. Diagnosis of extraosseous Ewing's sarcoma for patients
• • 4. Age at diagnosis \<50 years
• • 5. Assessment of the extent of the disease at onset in accordance with the European Society of Medical Oncology guidelines
• • 6. Patients or parents oe guardians of minors who have given their written informed consent to participate in the study
• Exclusion Criteria:
• • 1. Presence of comorbid factors who can compromise the compliance of the treatment plan or the evaluation of the outcomes, including but not limited to organ pathologies that contraindicate the use of chemotherapy and psychological or social conditions that do not allow for adequate compliance treatment or adequate follow-up